Canakinumab in the routinary clinical practice in cryopyrin-associated periodic syndromes (CAPS): one year of follow-up

مواد مشابهة

• Canakinumab in the routinary clinical practice in cryopyrin-associated periodic syndromes (CAPS): one year of follow-up
  بواسطة: Caorsi, R, وآخرون
  منشور في: (2011)
• The schedule of administration of canakinumab in cryopyrin associated periodic syndrome is driven by the phenotype severity rather than the age
  بواسطة: Caorsi, Roberta, وآخرون
  منشور في: (2013)
• National CAPS (Cryopyrin-Associated Periodic Syndrome) Registry
  بواسطة: Bibalo, C, وآخرون
  منشور في: (2011)
• Critical appraisal of canakinumab in the treatment of adults and children with cryopyrin-associated periodic syndrome (CAPS)
  بواسطة: Toker, Ori, وآخرون
  منشور في: (2010)
• The interleukin 1 inhibitor canakinumab in the treatment of cryopyrin-associated periodic syndromes (CAPS): clinical experience
  بواسطة: Svetlana Olegovna Salugina, وآخرون
  منشور في: (2014-12-01)